• Blog
  • Specimen Validity Testing Market Growth Analysis | 2023-2028

    Specimen Validity Testing Market Growth Analysis | 2023-2028

    Specimen Validity Testing Market Growth Analysis | 2023-2028
    Report code - SRHL121 Delivery - 2 Weeks
    Specimen Validity Testing Market Size, Share, Trends, Forecast, & Growth Analysis-&nbs See more...

    Market Insights

    The specimen validity testing market was estimated at USD 1.34 billion in 2022 and is likely to grow at a CAGR of 6.39% during 2023-2028 to reach USD 1.95 billion in 2028.

    Specimen-Validity-Testing-Market-Insights

    Want to know more about the market scope? Register Here

    What is a specimen validity test?

    Specimen validity tests, also known as testing for nitrates or Test Sure, are performed on a urine drug screen specimen to detect substitution, adulteration, or dilution. A drug-testing program detects people who have used drugs. The test determines whether a urine specimen has been adulterated, diluted, or substituted.

    Specimen Validity Testing Market Highlights

    Market Size in 2022

    USD 1.34 billion

    Market Size in 2028

    USD 1.95 billion

    Market Growth (2023-2028)

    6.45% CAGR

    Base Year of Study

    2022

    Trend Period

    2017-2021

    Forecast Period

    2023-2028

    Market Dynamics

    Major factors such as increasing illegal drug-related activities, stringent drug-screening regulations, and increasing government investment to combat drug abuse are expected to drive market growth during the forecast period. Furthermore, rising demand for presumptive tests, growing consumption of illicit drugs among the younger generation, and the adoption of drug screening tests at the workplace are all expected to have a significant impact on the demand for the market.

    Specimen-Validity-Testing-Market-Dynamics

    Want to have a closer look at this market report? Click Here

    Segments Analysis

    By Products & Services Type

    Based on the products & services type, the market is segmented as products and services. The products segment is further sub-segmented as reagents, calibrators, and controls; assay kits; and disposables. The reagents, calibrators, and controls sub-segment is expected to dominate the market during the forecast period, owing to the increasing demand for reagents and rapid screening kits in drug screening laboratories.

    By Testing Type

    Based on the testing type, the market is segmented as laboratory testing and rapid/POC testing. Rapid/POC testing is expected to grow at a higher CAGR in the market during the forecast period. The benefits of instant results, the ability to detect multiple drugs at once, and the recurrent and repetitive use of rapid/POC drug testing products are driving the segment's growth.

    Regional Insights

    In terms of regions, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Among these regions, North America is the dominant region in the market due to stringent laws for drug screening, increasing government investment to control drug abuse, and an increase in the consumption of illicit drugs. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.

    Specimen-Validity-Testing-Market-Regional-Insights

    Know the high-growth countries in this report. Click Here

    Market Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The market is segmented into the following categories.

    By Products & Services Type

    • Products
    • Services

    By Testing Type

    • Laboratory Testing
    • Rapid/POC Testing

    By End-User Type

    • Workplaces
    • Drug Screening Laboratories
    • Criminal Justice and Law Enforcement Agencies
    • Pain Management Centers
    • Drug Rehabilitation Centers
    • Others

    By Region

    • North America (Country Analysis: the USA, Canada, and Mexico)
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and the Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and the Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Specimen-Validity-Testing-Market-Segmentation

    Want to know the most attractive market segments? Register Here

    Key Players

    Some of the key players in the market are-

    • ACM Global Laboratories.
    • Alfa Scientific Designs, Inc.
    • American Bio Medica Corporation
    • Clinical Reference Laboratory, Inc.
    • GenomeWeb LLC.
    • Laboratory Corporation of America
    • Premier Biotech, Inc.
    • Quest Diagnostics Incorporated.
    • Sciteck, Inc.
    • Thermo Fisher Scientific Inc.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Specimen Validity Testing Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation by any one of the products & services type by testing type.

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Specimen validity tests, also known as testing for nitrates or Test Sure, are performed on a urine drug screen specimen to detect substitution, adulteration, or dilution. A drug-testing program detects people who have used drugs. The test determines whether a urine specimen has been adulterated, diluted, or substituted.

    The specimen validity testing market was estimated at USD 1.34 billion in 2022.

    The specimen validity testing market is likely to reach USD 1.95 billion in 2028.

    The specimen validity testing market is expected to witness an impressive growth of 6.39% CAGR during 2023-2028.

    ACM Global Laboratories., Alfa Scientific Designs, Inc., American Bio Medica Corporation, Clinical Reference Laboratory, Inc., GenomeWeb LLC., Laboratory Corporation of America, Premier Biotech, Inc., Quest Diagnostics Incorporated., Sciteck, Inc., and Thermo Fisher Scientific Inc are among the key players in the market.

    The reagents, calibrators, and controls sub-segment is expected to dominate the market in the next five years.

    North America is the dominant region in the market.

    Increasing illegal drug-related activities, stringent drug-screening regulations, and increasing government investment to combat drug abuse are the factors driving the growth of the market.